Tag Archives: Eli Lilly and Company

Daiichi Sankyo Chief Talks Effient

By George Koroneos | Published: July 15, 2009
FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a [...]
Posted in News, Strategy, Technology | Also tagged , , , , , | 2 Comments

Amylin Drops 200 Sales Reps

By George Koroneos | Published: May 6, 2009
Image via Wikipedia Biotech firm Amylin, on Monday, announced that it would trim its sales force by 200, or about 35 percent of its total. The move is expected to save the company about $65 million by 2010, and comes on the heels of an announcement that the company asked FDA to consider a once-weekly injectable [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment